Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis

• Status: Completed
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Roflumilast compare with placebo for decrease infected exacerbation in non-cystic Bronchiectasis

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Prince of Songkla University

Criteria

Inclusion Criteria:

• symptomatic Bronchiectasis

• history at least 2 exacerbation last year

Exclusion Criteria:

• comorbidity with chronic obstructive pulmonary disease